Actelion Company Profile (OTCMKTS:ALIOF)

About Actelion

Actelion logoActelion Ltd is a Switzerland-based biopharmaceutical company that focuses on the discovery, development and commercialization of drugs for diseases with unmet medical needs. The Company specializes in the field of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs. Its portfolio of PAH treatments includes Opsumit (macitentan), Tracleer (bosentan), Uptravi (selexipag), Veletri (epoprostenol for injection) and Ventavis (iloprost). Opsumit is an orally available endothelin receptor antagonist (ERA). Tracleer is an orally available endothelin receptor antagonist (ERA). Uptravi is an oral, selective IP receptor agonist targeting the prostacyclin pathway in PAH. Veletri (epoprostenol for injection) is an intravenous prostacyclin. Ventavis is an inhaled formulation of iloprost, a synthetic compound similar to prostacyclin (PGI2).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: ALIOF
  • CUSIP:
Key Metrics:
  • Previous Close: $172.60
  • 50 Day Moving Average: $169.18
  • 200 Day Moving Average: $162.47
  • 52-Week Range: $122.00 - $175.71
  • Trailing P/E Ratio: 29.54
  • Foreward P/E Ratio: 21.58
  • P/E Growth: 0.00
  • Market Cap: $18.15B
  • Outstanding Shares: 105,185,000
  • Beta: 1.32
Profitability:
  • Net Margins: 27.07%
  • Return on Equity: 47.08%
  • Return on Assets: 30.95%
Debt:
  • Current Ratio: 2.56%
  • Quick Ratio: 2.32%
Additional Links:
Companies Related to Actelion:

Analyst Ratings

Consensus Ratings for Actelion (OTCMKTS:ALIOF) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Actelion (OTCMKTS:ALIOF)
Show:
DateFirmActionRatingPrice TargetDetails
6/25/2015HSBCInitiated CoverageHoldView Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for Actelion (OTCMKTS:ALIOF)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/20/2015$1.61$1.90ViewN/AView Earnings Details
4/21/2015$1.28$1.68ViewN/AView Earnings Details
2/16/2015$1.13$0.81ViewN/AView Earnings Details
10/21/2014$1.50$1.61ViewN/AView Earnings Details
7/23/2014$1.37$2.00ViewN/AView Earnings Details
4/21/2014$1.12$1.65ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Actelion (OTCMKTS:ALIOF)
Current Year EPS Consensus Estimate: $8.36 EPS
Next Year EPS Consensus Estimate: $8 EPS

Dividends

Dividend History for Actelion (OTCMKTS:ALIOF)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Actelion (OTCMKTS:ALIOF)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Actelion (OTCMKTS:ALIOF)
DateHeadline
publicnow.com logoActelion to investigate all-oral combination therapy for patients with relapsing multiple sclerosis (OTCMKTS:ALIOF)
www.publicnow.com - September 29 at 8:12 AM
capitalcube.com logoActelion Ltd. – Value Analysis (US OTC:ALIOF) : September 21, 2016 (OTCMKTS:ALIOF)
www.capitalcube.com - September 21 at 4:20 PM
capitalcube.com logoActelion Ltd. breached its 50 day moving average in a Bullish Manner : ALIOF-US : September 20, 2016 (OTCMKTS:ALIOF)
www.capitalcube.com - September 20 at 9:15 AM
finance.yahoo.com logoDynavax Rebounds on Same PDUFA Date for Heplisav BLA (OTCMKTS:ALIOF)
finance.yahoo.com - September 7 at 12:23 PM
zacks.com logoWhy Actelion (ALIOF) Isn't Done Growing Earnings Yet (OTCMKTS:ALIOF)
www.zacks.com - September 2 at 8:04 AM
finance.yahoo.com logoPfizer's Lung Cancer Drug Xalkori Label Expanded in the EU (OTCMKTS:ALIOF)
finance.yahoo.com - September 1 at 11:57 AM
finance.yahoo.com logoArray (ARRY) Presents Positive Cardiovascular Trial Data (OTCMKTS:ALIOF)
finance.yahoo.com - August 31 at 3:29 PM
finance.yahoo.com logoAmgen Gets CRL for Secondary Hyperparathyroidism Drug (OTCMKTS:ALIOF)
finance.yahoo.com - August 25 at 3:28 PM
finance.yahoo.com logoPfizer to Acquire Rights to AstraZeneca's Antibiotics Business (OTCMKTS:ALIOF)
finance.yahoo.com - August 24 at 11:43 AM
finance.yahoo.com logoGalapagos (GLPG) Advances RA Drug Filgotinib to Phase III (OTCMKTS:ALIOF)
finance.yahoo.com - August 23 at 3:26 PM
capitalcube.com logoETF’s with exposure to Actelion Ltd. : August 23, 2016 (OTCMKTS:ALIOF)
www.capitalcube.com - August 23 at 3:26 PM
finance.yahoo.com logoPfizer to Buy Medivation for $14B, Boost Cancer Franchise (revised) (OTCMKTS:ALIOF)
finance.yahoo.com - August 23 at 8:26 AM
finance.yahoo.com logoPfizer-Medivation Close to Signing $14B Acquisition Deal? (revised) (OTCMKTS:ALIOF)
finance.yahoo.com - August 22 at 8:35 PM
publicnow.com logoActelion completes first-line share purchase program (OTCMKTS:ALIOF)
www.publicnow.com - August 22 at 8:13 AM
finance.yahoo.com logoPfizer-Medivation Close to Signing $14B Acquisition Deal? (OTCMKTS:ALIOF)
finance.yahoo.com - August 22 at 8:13 AM
finance.yahoo.com logoIntercept (ICPT) Ocaliva Phase III POISE Data Published (OTCMKTS:ALIOF)
finance.yahoo.com - August 18 at 11:49 AM
finance.yahoo.com logoCytokinetics' Amyotrophic Lateral Sclerosis Study Enrolled (OTCMKTS:ALIOF)
finance.yahoo.com - August 18 at 11:49 AM
finance.yahoo.com logoActelion (ALIOF) Uptravi Approved for PAH in Switzerland (OTCMKTS:ALIOF)
finance.yahoo.com - August 17 at 11:39 AM
finance.yahoo.com logoGlaxo/Pfizer ViiV Healthcare Starts HIV Drug Combo Study (OTCMKTS:ALIOF)
finance.yahoo.com - August 17 at 11:39 AM
4-traders.com logoActelion : receives Swissmedic approval for Uptravi (selexipag) for treatment of pulmonary arterial hypertension (OTCMKTS:ALIOF)
www.4-traders.com - August 16 at 8:44 PM
publicnow.com logoActelion receives Swissmedic approval for Uptravi (selexipag) for treatment of pulmonary arterial hypertension (OTCMKTS:ALIOF)
www.publicnow.com - August 16 at 12:01 PM
finance.yahoo.com logoIs ACTELION (ALIOF) Stock a Solid Choice Right Now? (OTCMKTS:ALIOF)
finance.yahoo.com - August 12 at 12:00 PM
capitalcube.com logoETF’s with exposure to Actelion Ltd. : August 10, 2016 (OTCMKTS:ALIOF)
www.capitalcube.com - August 10 at 3:47 PM
capitalcube.com logoActelion Ltd. breached its 50 day moving average in a Bearish Manner : ALIOF-US : August 9, 2016 (OTCMKTS:ALIOF)
www.capitalcube.com - August 9 at 12:11 PM
capitalcube.com logoActelion Ltd. :ALIOF-US: Earnings Analysis: Q2, 2016 By the Numbers : August 2, 2016 (OTCMKTS:ALIOF)
www.capitalcube.com - August 2 at 3:27 PM
finance.yahoo.com logoWhy ACTELION (ALIOF) Could Be an Impressive Growth Stock (OTCMKTS:ALIOF)
finance.yahoo.com - July 28 at 8:37 AM
finance.yahoo.com logoActelion (ALIOF) Beats Q2 Earnings & Revenues, View Up (OTCMKTS:ALIOF)
finance.yahoo.com - July 22 at 1:13 PM
News IconActelion H1 Net Income Rises (OTCMKTS:ALIOF)
potiner.com - July 21 at 9:00 PM
nasdaq.com logoActelion H1 Net Income Rises - Quick Facts (OTCMKTS:ALIOF)
www.nasdaq.com - July 21 at 9:00 PM
capitalcube.com logoETF’s with exposure to Actelion Ltd. : July 19, 2016 (OTCMKTS:ALIOF)
www.capitalcube.com - July 19 at 11:56 AM
capitalcube.com logoActelion Ltd. :ALIOF-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 (OTCMKTS:ALIOF)
www.capitalcube.com - June 28 at 11:14 AM
capitalcube.com logoActelion Ltd. breached its 50 day moving average in a Bearish Manner : ALIOF-US : June 27, 2016 (OTCMKTS:ALIOF)
www.capitalcube.com - June 27 at 11:12 AM
capitalcube.com logoActelion Ltd. – Value Analysis (US OTC:ALIOF) : June 17, 2016 (OTCMKTS:ALIOF)
www.capitalcube.com - June 17 at 11:50 AM
capitalcube.com logoActelion Ltd. breached its 50 day moving average in a Bearish Manner : ALIOF-US : June 15, 2016 (OTCMKTS:ALIOF)
www.capitalcube.com - June 15 at 8:09 AM
capitalcube.com logoETF’s with exposure to Actelion Ltd. : April 22, 2016 (OTCMKTS:ALIOF)
www.capitalcube.com - April 22 at 3:01 PM
capitalcube.com logoActelion Ltd. :ALIOF-US: Earnings Analysis: Q1, 2016 By the Numbers (OTCMKTS:ALIOF)
www.capitalcube.com - April 22 at 9:19 AM
finance.yahoo.com logoClovis Hits 52-week Low Post Rociletinib Briefing Documents (OTCMKTS:ALIOF)
finance.yahoo.com - April 11 at 3:45 PM
finance.yahoo.com logoIonis Tanks, FDA Clinical Hold on IONIS-TTRRx Phase III Study (OTCMKTS:ALIOF)
finance.yahoo.com - April 8 at 4:40 PM
finance.yahoo.com logoIntercept's (ICPT) Ocaliva Gets Favorable FDA Panel Vote (OTCMKTS:ALIOF)
finance.yahoo.com - April 8 at 3:35 PM
finance.yahoo.com logoIllumina Unveils BaseSpace Suite, Boosts Precision Medicine (OTCMKTS:ALIOF)
finance.yahoo.com - April 8 at 1:55 PM
finance.yahoo.com logoIronwood Slumps, Halts Development of Gastroparesis Drug (OTCMKTS:ALIOF)
finance.yahoo.com - April 6 at 10:10 AM
finance.yahoo.com logoAbbVie Up, Wins CHMP Backing for Humira's Expanded Use (OTCMKTS:ALIOF)
finance.yahoo.com - April 5 at 11:20 AM
finance.yahoo.com logoSarepta's Q4 Loss Wider than Expected, Eteplirsen in Focus (OTCMKTS:ALIOF)
finance.yahoo.com - February 26 at 11:50 AM
finance.yahoo.com logoKeryx Posts Wider-than-Expected Loss in Q4, Auryxia Grows (OTCMKTS:ALIOF)
finance.yahoo.com - February 26 at 9:50 AM
finance.yahoo.com logoIonis Incurs Wider-than-Expected Loss in Q4, Shares Down (OTCMKTS:ALIOF)
finance.yahoo.com - February 26 at 9:45 AM
finance.yahoo.com logoGeron Q4 Loss In-Line with Estimates, Imetelstat in Focus (OTCMKTS:ALIOF)
finance.yahoo.com - February 26 at 9:35 AM
finance.yahoo.com logoAnika Therapeutics (ANIK) Jumps: Stock Moves Up 8% (OTCMKTS:ALIOF)
finance.yahoo.com - February 26 at 8:15 AM
nasdaq.com logoActelion Profit Jumps, Proposes Higher Dividend; Sees Growth In FY16 Core Income (OTCMKTS:ALIOF)
www.nasdaq.com - February 9 at 1:57 AM
capitalcube.com logoActelion Ltd. breached its 50 day moving average in a Bullish Manner : January 28, 2016 (OTCMKTS:ALIOF)
www.capitalcube.com - January 28 at 8:04 AM
finance.yahoo.com logoAlexion (ALXN) Gains after Kanuma Receives FDA Approval (OTCMKTS:ALIOF)
finance.yahoo.com - December 9 at 3:35 PM

Social

Actelion (OTCMKTS:ALIOF) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff